Christine Mulligan
Psychiatric/Mental Health · Devon, PANPI 1518989375
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,100 of the $15,625 with a category attached, or 77.4%. 16 manufacturers reported payments, led by Alkermes, Inc. at 47.7% of the total. Among psychiatric/mental health clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $118.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$7K
- AbbVie$7K
- Corium, LLC$461
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$174
- Amgen$88
- Otsuka America Pharmaceutical, Inc.$82
- plus $352 from 10 others
What the payments were for
- Speaking & faculty fees$12,10077%
- Travel & lodging$8846%
- Food & beverage$2,61417%
- Education$270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 21 | $7,457 |
| AbbVie | 46 | $7,011 |
| Corium, LLC | 33 | $461 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $174 |
| Amgen | 1 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Supernus Pharmaceuticals, Inc. | 5 | $75 |
| Collegium Pharmaceutical, Inc. | 3 | $65 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Ironshore Pharmaceuticals Inc. | 2 | $29 |
| Neurocrine Biosciences, Inc. | 1 | $29 |
| Lundbeck LLC | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Neos Therapeutics, LP | 1 | $20 |
| Tris Pharma Inc | 1 | $17 |
| Noven Therapeutics, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,625 in reported general payments places this provider in the 95th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.
See all psychiatric/mental health providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Temazepam | 11 | $1,873 |
| Methylphenidate ErMethylphenidate Hcl | 16 | $1,246 |
| Olanzapine | 23 | $537 |
| Aripiprazole | 21 | $414 |
| Armodafinil | 13 | $411 |
| Clonazepam | 22 | $340 |
| Bupropion XlBupropion Hcl | 14 | $260 |
| Guanfacine Hcl ErGuanfacine Hcl | 19 | $167 |
| Nortriptyline Hcl | 15 | $136 |
| Lithium Carbonate | 13 | $122 |
| Risperidone | 24 | $112 |
| Clonidine Hcl | 13 | $69 |
| Gabapentin | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Devon
- Kimberly GarciaAllentown$573K
- Cortney SmithWashington$227K
- Britney KeplerPittsburgh$158K
- Kirstyn KamegBethel Park$136K
- Anna DipietroDowningtown$131K
- Deena MasciocchiLanghorne$71K
- Joseph GagnonChesterbrook$64K
- Michelle CohenWashington$62K
- Sharon KatzJenkintown$51K
- Jennifer BowmanCanonsburg$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.